Clinical Trial Update: Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial assessed the efficacy and safety of adding sitagliptin to metformin in patients with type 2 diabetes mellitus with inadequate glycem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Status: COMPLETED | Results posted: 2011-04-20